Atlas Trials

Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action

Clinical trial NCT01439854 · COMPLETED

Trial details

NCT number
NCT01439854
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Insulin SensitivityMultiple Mitochondrial Dysfunctions Syndrome
Start date
2011-03-01
Primary completion
2018-06-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.